2. The drug behind Europe's most valuable company

from The Rest Is Money · host Goalhanger

How much harm has been done by decades of governments investing too little? Is buy-now-pay-later causing misery or joy for young shoppers? Are supermarkets cutting prices fast enough? Is Novo Nordisk’s anti obesity wonder drug Semaglutide the most important pharmaceutical discovery of the century? Join Robert and Steph as they answer all these questions and more on today's episode of The Rest Is Money. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Sep 6, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

2. The drug behind Europe's most valuable company

0:00 56:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Rest Is Money?

This episode is 56 minutes long.

When was this The Rest Is Money episode published?

This episode was published on September 6, 2023.

Can I download this The Rest Is Money episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!